Geographic Variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III Definitions of the Metabolic Syndrome in Nondiabetic Subjects
OBJECTIVE:--We have carried out international comparisons of the metabolic syndrome using the International Diabetes Federation (IDF) and National Cholesterol Education Program-Adult Treatment Panel III (ATP III) definitions. This analysis could help to discern the applicability of these definitions...
Saved in:
| Published in | Diabetes care Vol. 29; no. 3; pp. 685 - 691 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Alexandria, VA
American Diabetes Association
01.03.2006
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | OBJECTIVE:--We have carried out international comparisons of the metabolic syndrome using the International Diabetes Federation (IDF) and National Cholesterol Education Program-Adult Treatment Panel III (ATP III) definitions. This analysis could help to discern the applicability of these definitions across populations. RESEARCH DESIGN AND METHODS--Nondiabetic subjects aged 35-64 years were eligible for analysis in population-based studies from San Antonio (Mexican Americans and non-Hispanic whites, n = 2,473), Mexico City (n = 1,990), Spain (n = 2,540), and Peru (n = 346). [kappa] Statistics examined the agreement between metabolic syndrome definitions. RESULTS:--Because of the lower cutoff points for elevated waist circumference, the IDF definition of the metabolic syndrome generated greater prevalence estimates than the ATP III definition. Prevalence difference between definitions was more significant in Mexican-origin and Peruvian men than in Europid men from San Antonio and Spain because the IDF definition required ethnic group-specific cutoff points for elevated waist circumference. ATP III and IDF definitions disagreed in the classification of 13-29% of men and 3-7% of women. In men, agreement between these definitions was 0.54 in Peru, 0.43 in Mexico City, 0.62 in San Antonio Mexican Americans, 0.69 in San Antonio non-Hispanic whites, and 0.64 in Spain. In women, agreement between definitions was 0.87, 0.89, 0.86, 0.87, and 0.93, respectively. CONCLUSIONS:--The IDF definition of the metabolic syndrome generates greater prevalence estimates than the ATP III definition. Agreement between ATP III and IDF definitions was lower for men than for women in all populations and was relatively poor in men from Mexico City. |
|---|---|
| AbstractList | We have carried out international comparisons of the metabolic syndrome using the International Diabetes Federation (IDF) and National Cholesterol Education Program-Adult Treatment Panel III (ATP III) definitions. This analysis could help to discern the applicability of these definitions across populations. Nondiabetic subjects aged 35-64 years were eligible for analysis in population-based studies from San Antonio (Mexican Americans and non-Hispanic whites, n = 2,473), Mexico City (n = 1,990), Spain (n = 2,540), and Peru (n = 346). κ Statistics examined the agreement between metabolic syndrome definitions. Because of the lower cutoff points for elevated waist circumference, the IDF definition of the metabolic syndrome generated greater prevalence estimates than the ATP III definition. Prevalence difference between definitions was more significant in Mexican-origin and Peruvian men than in Europid men from San Antonio and Spain because the IDF definition required ethnic group-specific cutoff points for elevated waist circumference. ATP III and IDF definitions disagreed in the classification of 13-29% of men and 3-7% of women. In men, agreement between these definitions was 0.54 in Peru, 0.43 in Mexico City, 0.62 in San Antonio Mexican Americans, 0.69 in San Antonio non-Hispanic whites, and 0.64 in Spain. In women, agreement between definitions was 0.87, 0.89, 0.86, 0.87, and 0.93, respectively. The IDF definition of the metabolic syndrome generates greater prevalence estimates than the ATP III definition. Agreement between ATP III and IDF definitions was lower for men than for women in all populations and was relatively poor in men from Mexico City. We have carried out international comparisons of the metabolic syndrome using the International Diabetes Federation (IDF) and National Cholesterol Education Program-Adult Treatment Panel III (ATP III) definitions. This analysis could help to discern the applicability of these definitions across populations. Nondiabetic subjects aged 35-64 years were eligible for analysis in population-based studies from San Antonio (Mexican Americans and non-Hispanic whites, n = 2,473), Mexico City (n = 1,990), Spain (n = 2,540), and Peru (n = 346). Kappa statistics examined the agreement between metabolic syndrome definitions. Because of the lower cutoff points for elevated waist circumference, the IDF definition of the metabolic syndrome generated greater prevalence estimates than the ATP III definition. Prevalence difference between definitions was more significant in Mexican-origin and Peruvian men than in Europid men from San Antonio and Spain because the IDF definition required ethnic group-specific cutoff points for elevated waist circumference. ATP III and IDF definitions disagreed in the classification of 13-29% of men and 3-7% of women. In men, agreement between these definitions was 0.54 in Peru, 0.43 in Mexico City, 0.62 in San Antonio Mexican Americans, 0.69 in San Antonio non-Hispanic whites, and 0.64 in Spain. In women, agreement between definitions was 0.87, 0.89, 0.86, 0.87, and 0.93, respectively. The IDF definition of the metabolic syndrome generates greater prevalence estimates than the ATP III definition. Agreement between ATP III and IDF definitions was lower for men than for women in all populations and was relatively poor in men from Mexico City. OBJECTIVE:--We have carried out international comparisons of the metabolic syndrome using the International Diabetes Federation (IDF) and National Cholesterol Education Program-Adult Treatment Panel III (ATP III) definitions. This analysis could help to discern the applicability of these definitions across populations. RESEARCH DESIGN AND METHODS--Nondiabetic subjects aged 35-64 years were eligible for analysis in population-based studies from San Antonio (Mexican Americans and non-Hispanic whites, n = 2,473), Mexico City (n = 1,990), Spain (n = 2,540), and Peru (n = 346). [kappa] Statistics examined the agreement between metabolic syndrome definitions. RESULTS:--Because of the lower cutoff points for elevated waist circumference, the IDF definition of the metabolic syndrome generated greater prevalence estimates than the ATP III definition. Prevalence difference between definitions was more significant in Mexican-origin and Peruvian men than in Europid men from San Antonio and Spain because the IDF definition required ethnic group-specific cutoff points for elevated waist circumference. ATP III and IDF definitions disagreed in the classification of 13-29% of men and 3-7% of women. In men, agreement between these definitions was 0.54 in Peru, 0.43 in Mexico City, 0.62 in San Antonio Mexican Americans, 0.69 in San Antonio non-Hispanic whites, and 0.64 in Spain. In women, agreement between definitions was 0.87, 0.89, 0.86, 0.87, and 0.93, respectively. CONCLUSIONS:--The IDF definition of the metabolic syndrome generates greater prevalence estimates than the ATP III definition. Agreement between ATP III and IDF definitions was lower for men than for women in all populations and was relatively poor in men from Mexico City. OBJECTIVEWe have carried out international comparisons of the metabolic syndrome using the International Diabetes Federation (IDF) and National Cholesterol Education Program-Adult Treatment Panel III (ATP III) definitions. This analysis could help to discern the applicability of these definitions across populations.RESEARCH DESIGN AND METHODSNondiabetic subjects aged 35-64 years were eligible for analysis in population-based studies from San Antonio (Mexican Americans and non-Hispanic whites, n = 2,473), Mexico City (n = 1,990), Spain (n = 2,540), and Peru (n = 346). Kappa statistics examined the agreement between metabolic syndrome definitions.RESULTSBecause of the lower cutoff points for elevated waist circumference, the IDF definition of the metabolic syndrome generated greater prevalence estimates than the ATP III definition. Prevalence difference between definitions was more significant in Mexican-origin and Peruvian men than in Europid men from San Antonio and Spain because the IDF definition required ethnic group-specific cutoff points for elevated waist circumference. ATP III and IDF definitions disagreed in the classification of 13-29% of men and 3-7% of women. In men, agreement between these definitions was 0.54 in Peru, 0.43 in Mexico City, 0.62 in San Antonio Mexican Americans, 0.69 in San Antonio non-Hispanic whites, and 0.64 in Spain. In women, agreement between definitions was 0.87, 0.89, 0.86, 0.87, and 0.93, respectively.CONCLUSIONSThe IDF definition of the metabolic syndrome generates greater prevalence estimates than the ATP III definition. Agreement between ATP III and IDF definitions was lower for men than for women in all populations and was relatively poor in men from Mexico City. Geographic Variations of the International Diabetes Federation and the National Cholesterol Education Program–Adult Treatment Panel III Definitions of the Metabolic Syndrome in Nondiabetic Subjects Carlos Lorenzo , MD 1 , Manuel Serrano-Ríos , MD 2 , María T. Martínez-Larrad , PHD 2 , José L. González-Sánchez , PHD 2 , Segundo Seclén , MD 3 , Arturo Villena , MD 3 , Clicerio Gonzalez-Villalpando , MD 4 , Ken Williams , MS 1 and Steven M. Haffner , MD 1 1 Department of Medicine, University of Texas Health Science Center, San Antonio, Texas 2 Department of Medicine, Hospital Universitario San Carlos, Red de Centros de Metabolismo y Nutricion (RCMN) 03/08, Madrid, Spain 3 Diabetes Clinic, Cayetano Heredia Peruvian University, Lima, Peru 4 Centro de Estudios en Diabetes, Centro de Investigacion en Salud Poblacional, Instituto Nacional de la Salud Publica, Instituto Mexicano del Seguro Social, American British Cowdray Medical Center, Mexico City, Mexico Address correspondencereprint requests to Dr. Carlos Lorenzo, Division of Clinical Epidemiology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78284-7873. E-mail: lorenzo{at}uthscsa.edu Abstract OBJECTIVE —We have carried out international comparisons of the metabolic syndrome using the International Diabetes Federation (IDF) and National Cholesterol Education Program–Adult Treatment Panel III (ATP III) definitions. This analysis could help to discern the applicability of these definitions across populations. RESEARCH DESIGN AND METHODS —Nondiabetic subjects aged 35–64 years were eligible for analysis in population-based studies from San Antonio (Mexican Americans and non-Hispanic whites, n = 2,473), Mexico City ( n = 1,990), Spain ( n = 2,540), and Peru ( n = 346). κ Statistics examined the agreement between metabolic syndrome definitions. RESULTS —Because of the lower cutoff points for elevated waist circumference, the IDF definition of the metabolic syndrome generated greater prevalence estimates than the ATP III definition. Prevalence difference between definitions was more significant in Mexican-origin and Peruvian men than in Europid men from San Antonio and Spain because the IDF definition required ethnic group–specific cutoff points for elevated waist circumference. ATP III and IDF definitions disagreed in the classification of 13–29% of men and 3–7% of women. In men, agreement between these definitions was 0.54 in Peru, 0.43 in Mexico City, 0.62 in San Antonio Mexican Americans, 0.69 in San Antonio non-Hispanic whites, and 0.64 in Spain. In women, agreement between definitions was 0.87, 0.89, 0.86, 0.87, and 0.93, respectively. CONCLUSIONS —The IDF definition of the metabolic syndrome generates greater prevalence estimates than the ATP III definition. Agreement between ATP III and IDF definitions was lower for men than for women in all populations and was relatively poor in men from Mexico City. ATP III, Adult Treatment Panel III IDF, International Diabetes Federation MCDS, Mexico City Diabetes Study PIRS, Peruvian Insulin Resistance Study SAHS, San Antonio Heart Study SIRS, Spanish Insulin Resistance Study Footnotes A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Accepted December 4, 2005. Received September 22, 2005. DIABETES CARE OBJECTIVE—We have carried out international comparisons of the metabolic syndrome using the International Diabetes Federation (IDF) and National Cholesterol Education Program–Adult Treatment Panel III (ATP III) definitions. This analysis could help to discern the applicability of these definitions across populations. RESEARCH DESIGN AND METHODS—Nondiabetic subjects aged 35–64 years were eligible for analysis in population-based studies from San Antonio (Mexican Americans and non-Hispanic whites, n = 2,473), Mexico City (n = 1,990), Spain (n = 2,540), and Peru (n = 346). κ Statistics examined the agreement between metabolic syndrome definitions. RESULTS—Because of the lower cutoff points for elevated waist circumference, the IDF definition of the metabolic syndrome generated greater prevalence estimates than the ATP III definition. Prevalence difference between definitions was more significant in Mexican-origin and Peruvian men than in Europid men from San Antonio and Spain because the IDF definition required ethnic group–specific cutoff points for elevated waist circumference. ATP III and IDF definitions disagreed in the classification of 13–29% of men and 3–7% of women. In men, agreement between these definitions was 0.54 in Peru, 0.43 in Mexico City, 0.62 in San Antonio Mexican Americans, 0.69 in San Antonio non-Hispanic whites, and 0.64 in Spain. In women, agreement between definitions was 0.87, 0.89, 0.86, 0.87, and 0.93, respectively. CONCLUSIONS—The IDF definition of the metabolic syndrome generates greater prevalence estimates than the ATP III definition. Agreement between ATP III and IDF definitions was lower for men than for women in all populations and was relatively poor in men from Mexico City. |
| Audience | Professional |
| Author | González-Sánchez, José L Serrano-Ríos, Manuel Haffner, Steven M Lorenzo, Carlos Martínez-Larrad, María T Gonzalez-Villalpando, Clicerio Villena, Arturo Seclén, Segundo Williams, Ken |
| Author_xml | – sequence: 1 fullname: Lorenzo, Carlos – sequence: 2 fullname: Serrano-Ríos, Manuel – sequence: 3 fullname: Martínez-Larrad, María T – sequence: 4 fullname: González-Sánchez, José L – sequence: 5 fullname: Seclén, Segundo – sequence: 6 fullname: Villena, Arturo – sequence: 7 fullname: Gonzalez-Villalpando, Clicerio – sequence: 8 fullname: Williams, Ken – sequence: 9 fullname: Haffner, Steven M |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17560614$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16505527$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkltrFDEYhgep2Hb1L2goKHgxaw6TOXi3bA8u1Fpo623IJN_sZskkazKD9Af6v8wepColFyEfz5vv9J5mR847yLIzgqeUseqTNlLJAFPaTDGb4nKqFeY5qZryRXZCGsZzzov6KDvBpGhy3jT0ODuNcY0xLoq6fpUdk5Jjzml1kv26Ar8McrMyCn2XwcjBeBeR79CwArRwAwS3i0mLzo1sYYCILkFD2EWRdHpH3vyB5itvISaZt-hCj2qP3YZtlj6f6dEO6D6AHHpwA7qVDixaLBboHDrjzD_Zv8IgW29TZXePTgffAzIO3Xind4Vs42O7BjXE19nLTtoIbw73JHu4vLiff8mvv10t5rPrXPGSDLmqC0YqwrBsugYkL1TBa81rCS3HJYdWp3etoCAF7yhXtKWacdy2RclkAw2bZB_2_26C_zGmNkVvogJrUxt-jKKsKsxISRJ49h-49mOapI2CUoYZrVMpkyzfQ0tpQRjX-SFItQSXhmvTyjuTwjNSMFrgtMTET5_h09HQG_Ws4PNeoIKPMUAnNsH0MjwKgsXWSuJgJUEbgZnApdhaSWytlMRvDy2MbQ_6SXrwTgLeHwAZlbRdkE6Z-MRVvMQl2bb5cc-tzHL106Rs-mCkv9MzUdY8se_2bCe9kMuQ_nu4ozitjGDeUMzYb9OD8K8 |
| CODEN | DICAD2 |
| CitedBy_id | crossref_primary_10_12968_bjca_2007_2_1_22637 crossref_primary_10_2337_dc06_2627 crossref_primary_10_1016_j_diabres_2007_04_004 crossref_primary_10_1530_EJE_11_0599 crossref_primary_10_1089_met_2006_0019 crossref_primary_10_1016_j_mcna_2011_06_001 crossref_primary_10_1111_j_1365_2362_2009_02191_x crossref_primary_10_1007_s00439_008_0540_6 crossref_primary_10_1016_j_diabres_2009_03_005 crossref_primary_10_1586_erc_11_9 crossref_primary_10_1016_j_hipert_2011_05_004 crossref_primary_10_1089_met_2007_0024 crossref_primary_10_1016_j_numecd_2008_07_010 crossref_primary_10_1016_j_ahj_2009_12_022 crossref_primary_10_1016_j_jcjd_2013_09_003 crossref_primary_10_1002_dmrr_763 crossref_primary_10_2337_dc07_0186 crossref_primary_10_2337_dc07_0460 crossref_primary_10_1161_ATVBAHA_107_151092 crossref_primary_10_1097_QAI_0b013e318074ef83 crossref_primary_10_1210_er_2008_0024 crossref_primary_10_1016_S2213_8587_14_70032_4 crossref_primary_10_1007_s40292_016_0137_4 crossref_primary_10_1016_j_metabol_2008_04_017 crossref_primary_10_1080_22201009_2007_10872151 crossref_primary_10_2105_AJPH_2008_141903 crossref_primary_10_1186_s12967_015_0762_z crossref_primary_10_1016_j_gheart_2013_10_001 crossref_primary_10_1111_j_1753_4887_2009_00173_x crossref_primary_10_1089_met_2010_0129 crossref_primary_10_3390_healthcare11040531 crossref_primary_10_1016_j_diabres_2009_12_025 crossref_primary_10_1139_h06_099 crossref_primary_10_1016_j_puhe_2011_11_003 crossref_primary_10_1007_s11845_008_0269_1 crossref_primary_10_1016_j_diabres_2006_11_013 crossref_primary_10_1016_j_acvd_2008_06_011 crossref_primary_10_1016_S1726_4901_08_70168_0 crossref_primary_10_1097_HJH_0b013e328048d004 crossref_primary_10_1139_H08_003 crossref_primary_10_1089_jwh_2007_0536 crossref_primary_10_1093_gerona_glp004 crossref_primary_10_1016_S0014_2565_09_70627_7 crossref_primary_10_3132_dvdr_2007_003 crossref_primary_10_1016_j_copbio_2008_02_005 crossref_primary_10_1371_journal_pone_0257306 crossref_primary_10_1002_dmrr_668 crossref_primary_10_1016_j_arcmed_2007_11_002 crossref_primary_10_2337_dc06_2484 crossref_primary_10_1016_j_bbr_2021_113662 crossref_primary_10_1089_met_2012_0115 crossref_primary_10_1089_met_2013_0092 crossref_primary_10_1097_MOL_0b013e3283295e96 crossref_primary_10_1016_j_amjcard_2008_02_096 crossref_primary_10_1089_met_2008_0009 crossref_primary_10_1016_j_ecl_2008_05_002 crossref_primary_10_1089_met_2007_0039 crossref_primary_10_1016_j_jcjd_2016_05_011 |
| Cites_doi | 10.2337/diabetes.52.8.2160 10.1038/sj.ejcn.1601716 10.1161/hy0202.103439 10.2337/diacare.28.7.1769 10.1038/oby.2003.198 10.2337/diacare.27.10.2444 10.1093/ajcn/42.6.1266 10.2337/diacare.28.9.2289 10.1038/sj.ejcn.1601414 10.1210/jcem.76.3.8445008 10.1016/0026-0495(90)90130-5 10.1001/jama.287.3.356 10.1016/S0140-6736(05)67402-8 10.1161/01.CIR.0000111245.75752.C6 10.4159/harvard.9780674497887 10.1002/ajhb.10083 10.1001/archinte.159.13.1450 10.1373/clinchem.2005.050989 10.1161/01.CIR.90.3.1542 10.2337/diacare.46.10.1594 10.2337/diab.41.4.484 10.1001/jama.285.19.2486 10.2337/diacare.20.7.1183 |
| ContentType | Journal Article |
| Copyright | 2006 INIST-CNRS COPYRIGHT 2006 American Diabetes Association Copyright American Diabetes Association Mar 2006 |
| Copyright_xml | – notice: 2006 INIST-CNRS – notice: COPYRIGHT 2006 American Diabetes Association – notice: Copyright American Diabetes Association Mar 2006 |
| DBID | FBQ IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7X2 7X7 7XB 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 ATCPS AZQEC BEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K9- K9. KB0 M0K M0R M0S M0T M1P M2O M2P MBDVC NAPCQ PQEST PQQKQ PQUKI PRINS Q9U S0X 7X8 |
| DOI | 10.2337/diacare.29.03.06.dc05-1796 |
| DatabaseName | AGRIS Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database Agricultural Science Collection PHMC-Proquest健康医学期刊库 ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central British Nursing Database Agricultural & Environmental Science Collection ProQuest Central Essentials eLibrary AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Agricultural Science Database Consumer Health Database Health & Medical Collection (Alumni Edition) Healthcare Administration Database Medical Database Research Library ProQuest Science Journals Research Library (Corporate) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic SIRS Editorial MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Agricultural Science Database Research Library Prep ProQuest Central Student ProQuest Central Essentials SIRS Editorial elibrary ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Agricultural & Environmental Science Collection ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Science Journals (Alumni Edition) ProQuest Central Basic ProQuest Science Journals ProQuest Family Health ProQuest One Academic Eastern Edition Agricultural Science Collection British Nursing Index with Full Text ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Agricultural Science Database MEDLINE MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database – sequence: 4 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1935-5548 |
| EndPage | 691 |
| ExternalDocumentID | 1005241381 A143240992 10_2337_diacare_29_03_06_dc05_1796 16505527 17560614 diacare_29_3_685 US201301059203 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | Mexico Texas Spain South America Central America United States Europe America North America Peru |
| GeographicLocations_xml | – name: Texas – name: Mexico – name: Spain – name: United States |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL 24799 – fundername: NHLBI NIH HHS grantid: R01 HL 36820 |
| GroupedDBID | --- -ET ..I .55 .GJ .XZ 08P 0R~ 18M 29F 2WC 3O- 3V. 4.4 41~ 53G 5GY 5RE 5RS 5VS 6PF 7RV 7X2 7X7 88E 88I 8AF 8AO 8C1 8F7 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AAIKC AAKAS AAMNW AAQQT AAWTL AAYEP AAYJJ ABOCM ABPPZ ABPTK ABUWG ACGFO ACGOD ADBBV ADZCM AEGXH AENEX AEQTP AERZD AFDAS AFFNX AFKRA AFOSN AFRAH AHMBA AI. AIAGR ALMA_UNASSIGNED_HOLDINGS AN0 AQUVI ATCPS AZQEC BAWUL BCR BCU BEC BENPR BHPHI BKEYQ BKNYI BLC BNQBC BPHCQ BR5 BTFSW BVXVI C1A CCPQU CS3 DIK DU5 DWQXO E3Z EBS EDB EJD EMOBN EX3 F5P FBQ FYUFA GNUQQ GUQSH GX1 HCIFZ HMCUK HZ~ IAG IAO IEA IGG IHR INH INR IOF IPO ITC J5H K9- KQ8 L7B M0K M0R M0T M1P M2O M2P M2Q M5~ N4W NAPCQ O5R O5S O9- OK1 OVD P2P PCD PEA PQQKQ PROAC PSQYO Q2X RHF RHI S0X SJFOW SV3 TDI TEORI TR2 TWZ UKHRP VH1 VVN W8F WH7 WHG WOQ WOW X7M YHG YOC ZA5 ZCG ZGI ZXP ~KM - 0R 1AW 55 AASXA ABFLS ACJLH ACVYA ADACO ADBIT BBAFP ET GJ H13 HZ KM M5 MBDVC O0- PADUT PQEST PQUKI PRINS XZ 08R AAUGY IQODW AAQOH ALIPV CGR CUY CVF ECM EIF NPM AAYXX CITATION AHPSJ 7XB 8FK K9. Q9U 7X8 |
| ID | FETCH-LOGICAL-c561t-c84317130a9f9ea54c458d58aeb5065ebd4588ce4145f25c2b2d350bb463a9e93 |
| IEDL.DBID | BENPR |
| ISSN | 0149-5992 |
| IngestDate | Sun Sep 29 08:09:32 EDT 2024 Thu Oct 10 22:15:09 EDT 2024 Tue Oct 22 21:08:34 EDT 2024 Fri Feb 02 04:42:01 EST 2024 Fri Aug 23 01:52:44 EDT 2024 Sat Sep 28 08:38:42 EDT 2024 Sun Oct 22 16:05:10 EDT 2023 Fri Jan 15 19:48:07 EST 2021 Wed Dec 27 19:11:02 EST 2023 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Endocrinopathy Human Definition Cardiovascular disease Metabolic diseases Hyperlipoproteinemia Adult Treatment Panel III Waist circumference X Syndrome Dyslipemia Comparative study Public health Geographical variation International |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c561t-c84317130a9f9ea54c458d58aeb5065ebd4588ce4145f25c2b2d350bb463a9e93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://diabetesjournals.org/care/article-pdf/29/3/685/593740/zdc00306000685.pdf |
| PMID | 16505527 |
| PQID | 223032884 |
| PQPubID | 47715 |
| PageCount | 7 |
| ParticipantIDs | crossref_primary_10_2337_diacare_29_03_06_dc05_1796 gale_infotracgeneralonefile_A143240992 proquest_journals_223032884 pubmed_primary_16505527 highwire_diabetes_diacare_29_3_685 pascalfrancis_primary_17560614 fao_agris_US201301059203 proquest_miscellaneous_67703161 gale_infotracacademiconefile_A143240992 |
| ProviderPackageCode | RHF RHI |
| PublicationCentury | 2000 |
| PublicationDate | 2006-03-01 |
| PublicationDateYYYYMMDD | 2006-03-01 |
| PublicationDate_xml | – month: 03 year: 2006 text: 2006-03-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | Alexandria, VA |
| PublicationPlace_xml | – name: Alexandria, VA – name: United States – name: Alexandria |
| PublicationTitle | Diabetes care |
| PublicationTitleAlternate | Diabetes Care |
| PublicationYear | 2006 |
| Publisher | American Diabetes Association |
| Publisher_xml | – name: American Diabetes Association |
| References | 2022031217090336200_R17 2022031217090336200_R18 2022031217090336200_R19 2022031217090336200_R13 2022031217090336200_R14 2022031217090336200_R15 2022031217090336200_R16 2022031217090336200_R10 2022031217090336200_R11 2022031217090336200_R12 2022031217090336200_R7 2022031217090336200_R6 2022031217090336200_R9 2022031217090336200_R8 2022031217090336200_R3 2022031217090336200_R2 2022031217090336200_R5 2022031217090336200_R4 2022031217090336200_R1 2022031217090336200_R24 2022031217090336200_R25 2022031217090336200_R26 2022031217090336200_R20 2022031217090336200_R21 2022031217090336200_R22 2022031217090336200_R23 |
| References_xml | – ident: 2022031217090336200_R10 doi: 10.2337/diabetes.52.8.2160 – ident: 2022031217090336200_R24 doi: 10.1038/sj.ejcn.1601716 – ident: 2022031217090336200_R14 doi: 10.1161/hy0202.103439 – ident: 2022031217090336200_R3 doi: 10.2337/diacare.28.7.1769 – ident: 2022031217090336200_R9 doi: 10.1038/oby.2003.198 – ident: 2022031217090336200_R17 doi: 10.2337/diacare.27.10.2444 – ident: 2022031217090336200_R22 doi: 10.1093/ajcn/42.6.1266 – ident: 2022031217090336200_R4 doi: 10.2337/diacare.28.9.2289 – ident: 2022031217090336200_R25 doi: 10.1038/sj.ejcn.1601414 – ident: 2022031217090336200_R1 – ident: 2022031217090336200_R19 doi: 10.1210/jcem.76.3.8445008 – ident: 2022031217090336200_R21 doi: 10.1016/0026-0495(90)90130-5 – ident: 2022031217090336200_R20 doi: 10.1001/jama.287.3.356 – ident: 2022031217090336200_R6 doi: 10.1016/S0140-6736(05)67402-8 – ident: 2022031217090336200_R11 doi: 10.1161/01.CIR.0000111245.75752.C6 – ident: 2022031217090336200_R7 doi: 10.4159/harvard.9780674497887 – ident: 2022031217090336200_R8 doi: 10.1002/ajhb.10083 – ident: 2022031217090336200_R12 doi: 10.1001/archinte.159.13.1450 – ident: 2022031217090336200_R26 – ident: 2022031217090336200_R15 – ident: 2022031217090336200_R5 doi: 10.1373/clinchem.2005.050989 – ident: 2022031217090336200_R13 doi: 10.1161/01.CIR.90.3.1542 – ident: 2022031217090336200_R18 doi: 10.2337/diacare.46.10.1594 – ident: 2022031217090336200_R23 doi: 10.2337/diab.41.4.484 – ident: 2022031217090336200_R2 doi: 10.1001/jama.285.19.2486 – ident: 2022031217090336200_R16 doi: 10.2337/diacare.20.7.1183 |
| SSID | ssj0004488 |
| Score | 2.187411 |
| Snippet | OBJECTIVE:--We have carried out international comparisons of the metabolic syndrome using the International Diabetes Federation (IDF) and National Cholesterol... Geographic Variations of the International Diabetes Federation and the National Cholesterol Education Program–Adult Treatment Panel III Definitions of the... We have carried out international comparisons of the metabolic syndrome using the International Diabetes Federation (IDF) and National Cholesterol Education... OBJECTIVE—We have carried out international comparisons of the metabolic syndrome using the International Diabetes Federation (IDF) and National Cholesterol... OBJECTIVEWe have carried out international comparisons of the metabolic syndrome using the International Diabetes Federation (IDF) and National Cholesterol... |
| SourceID | proquest gale crossref pubmed pascalfrancis highwire fao |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 685 |
| SubjectTerms | Adult Adults Biological and medical sciences Care and treatment Cholesterol Diabetes Diabetes. Impaired glucose tolerance Diabetics Disorders of blood lipids. Hyperlipoproteinemia Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Federations Female Health aspects Health education Health Surveys Humans Internationality Male Management Medical sciences Medical treatment Metabolic diseases Metabolic syndrome Metabolic Syndrome - classification Metabolic Syndrome - epidemiology Metabolic syndrome X Mexican Americans Mexicans Mexico - epidemiology Middle Aged Peru - epidemiology Prevalence Spain - epidemiology Texas - epidemiology Voluntary Health Agencies Whites |
| Title | Geographic Variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III Definitions of the Metabolic Syndrome in Nondiabetic Subjects |
| URI | http://care.diabetesjournals.org/content/29/3/685.abstract https://www.ncbi.nlm.nih.gov/pubmed/16505527 https://www.proquest.com/docview/223032884 https://search.proquest.com/docview/67703161 |
| Volume | 29 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfoJiFe0PhcGBQLIXjKlsR2Pp5QKatWpFUVW1HfrMR2RqUqGUv6J-7_4i522lUCXvKQWI6TO59_dz7_jpCPRaIFL2LlG5Yqn5cJ91MWMh88sRKZMWGR6rItZvHFgn9fiqXLzWlcWmVvEztDrWuFMfIzWMaQ-i3lX25_-1g0CjdXXQWNATmMQo67tIdfz2fzH7uDkbwrPIlugC-yLLKsoxFjyRn8fcytOo0syWl8qhVycibI3v9ghRqUeb2z1j2FMGZQ5g38xNJWv_g3PO2WqckReerwJR1ZhXhGHpnqOXl86XbQX5B7V_X810rRn-An24AdrUsKSJDuxQepy5Zp6AQZJ7q7NK9013LWNxpjgV1kW6jXdJstQuc27csfIb0Hve6z2ek8r8yaTqdT-s2Uq2q19_ZL04JKrmFkV45Hga4qOqsrGyDG-5sC40bNS7KYnF-PL3xXysFXANBaX6UIVGC9zLMyM7ngiotUizQ3hQAQZAqNJ2aV4SEXZSRUVESaiaAoeMzyzGTsFTmo6socE5pkWAIgYAqwCo-VKYJSK6W50uBu57HwCOvFJ28tY4cETweFLp3QZZTJgMkglih0iUL3yDFIWuY3YFrl4irCDV2EnlHAPPIZxS9xxrd30IE7uADDQe4sOQo7VkNQL4982mt5Y5nD_9bwQ69Kso-xPxwck3EKHzLcU7Ld1yQAUwFWeeSk1zrpLE8jt_PEI--3T8Fk4D4QiLjeNDJOsGhBHHrktVXVXc-A15GS781_ez4hT2wgCjPx3pKD9m5j3gE0a4shGSTLBK7pOBy6yfgHfCI5Rw |
| link.rule.ids | 315,786,790,12083,12250,21416,27955,27956,31752,31753,33299,33300,33777,33778,43343,43612,43838,74100,74369,74657 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFLXYkIAXxOeWDTYLIXjKlsYfSZ5QVahaWKtJa9HeLMdxRqUq2Zb2J_K_uDd22lUCXlPLdXKvr4-vj88l5GOeFILn0oSWpSbkZcLDlPVYCDuxEpUxYZFq2RZTOZrz79fi2nNzGk-r7GJiG6iL2mCO_ByWMZR-S_mX27sQi0bh4aqvoLFHHnMGSzVeFB9sGR6w80gdgzELRZbFTnM0Ziw5h2-PzKqz2EmcyrPCoCJngtr9D9anvVLX21jdCQgjf1I38AlLV_vi3-C0XaSGL8hzjy5p37nDS_LIVq_Ik4k_P39Nfvua578Whv6EXbJL19G6pIAD6U52kHquTEOHqDfRPqW6KtqW067RAMvrotZCvaQbrgi9dKSvsI_iHnTWcdnppa7sko7HY_rVlotqsfPvE7sCh1zCyK68igJdVHRaVy49jM_XOWaNmjdkPvw2G4xCX8ghNADPVqFJEabAaqmzMrNacMNFWohU21wABLJ5gfdljeU9LspYmDiPCyaiPOeS6cxm7C3Zr-rKHhKaZFgAIGIGkAqXxuZRWRhTcFPAZltLERDWmU_dOr0OBfscNLryRldxpiKmIqnQ6AqNHpBDsLTSNxBY1fwqxuNcBJ5xxALyGc2vcL6v7qEDf20BhoPKWarfazUNwb0C8mmn5Y3TDf9bww-dK6kuw_5wcEzJFF7kZMfJtm-TAEgFUBWQ487rlI87jdrMkoCcbn6FgIGnQGDiet0omWDJAtkLyIFz1W3PgNZRkO_ovz2fkqej2eRCXYynP47JM5eSQk7eO7K_ul_b9wDSVvlJOxX_AAorOOU |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELbYkCZeEL8XBpuFEDxlTeMfSZ5Q1VGtwKpKW9HeLMdxtkpVMpb0T-T_4i522lUCXlPLTXLnu8_nL98R8jFPCsFzaULLUhPyMuFhyoYshJ1YicqYkKQ6tsVMni_4t2tx7SWFGk-r7GNiF6iL2mCNfABpDKXfUj4oPStifjb5cvcrxAZSeNDqu2nskceQFCU6eDresj1gF5I6NmMWiiyLnf5ozFgyADsgy-o0dnKn8rQwqM6ZoI7_g1y1V-p6G7d7MWHkUuoGXmfp-mD8G6h2CWvyjDz1SJOOnGs8J49s9YIcXPiz9Jfkt-9_frs09CfsmF3pjtYlBUxIdyqF1PNmGjpB7YnuKtVV0Y2c9YPG2GoXdRfqFd3wRujcEcDCEQp90Kue107nurIrOp1O6Zktl9Vy598vbAvOuYI7u_SKCnRZ0VlduVIxXl_nWEFqXpHF5OvV-Dz0TR1CA1CtDU2KkAUyp87KzGrBDRdpIVJtcwFwyOYFfjtrLB9yUcbCxHlcMBHlOZdMZzZjr8l-VVf2kNAkw2YAETOAWrg0No_KwpiCmwI23lqKgLDefOrOaXco2POg0ZU3uoozFTEVSYVGV2j0gByCpZW-gSCrFpcxHu0iCI0jFpDPaH6Fa7-9hwn8JwxwO6iipUbDTt8Q3Csgn3ZG3jgN8b8N_NC7kuqr7Q9vjimZwoMc7zjZ9mkSAKwAsAJy1Hud8jGoUZsVE5CTza8QPPBECExcrxslE2xfIIcBeeNcdTszIHcU53v735lPyAGsQvVjOvt-RJ646hTS896R_fZ-bd8DXmvz424l_gEJ1z0j |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Geographic+variations+of+the+International+Diabetes+Federation+and+the+National+Cholesterol+Education+Program--Adult+Treatment+Panel+III+definitions+of+the+metabolic+syndrome+in+nondiabetic+subjects&rft.jtitle=Diabetes+care&rft.au=Lorenzo%2C+Carlos&rft.au=Serrano-Rios%2C+Manuel&rft.au=Martinez-Larrad%2C+Maria+T&rft.au=Gonzalez-Sanchez%2C+Jose+L&rft.date=2006-03-01&rft.pub=American+Diabetes+Association&rft.issn=0149-5992&rft.volume=29&rft.issue=3&rft.spage=685&rft_id=info:doi/10.2337%2Fdiacare.29.03.06.dc05-1796&rft.externalDocID=A143240992 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon |